stella
beta
Clinical Study of MSH2-/- Tumor Cell Vaccines for Advanced pMMR Colorectal Cancer Patients — Stella
Recruiting
Back to pMMR/MSS Advanced Colorectal Cancer trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(2 sites)
China
West China Hospital, Sichuan University, Chengdu, Sichuan
West China Hospital, Sichuan University, Chengdu, Sichuan
View full record on ClinicalTrials.gov